4//SEC Filing
Donadio Jamie A 4
Accession 0001214659-19-003693
CIK 0001576263other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 7:00 PM ET
Size
8.8 KB
Accession
0001214659-19-003693
Insider Transaction Report
Form 4
Donadio Jamie A
VP of Finance
Transactions
- Exercise/Conversion
Common Stock
2019-05-16$5.50/sh+7,500$41,250→ 7,721 total - Sale
Common Stock
2019-05-16$75.00/sh−7,500$562,500→ 221 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-05-16−7,500→ 13,125 totalExercise: $5.50Exp: 2026-10-26→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June14, 2018.
- [F2]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
Related Parties
1- filerCIK 0001579771
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 7:00 PM ET
- Size
- 8.8 KB